Den Europæiske Union - islandsk - EMA (European Medicines Agency)

janssen-cilag international n.v. - paliperidon palmitat - geðklofa - psycholeptics - xeplion er ætlað til viðhaldsmeðferðar við geðklofa hjá fullorðnum sjúklingum sem eru stöðugir með paliperidoni eða risperidoni. in selected adult patients with schizophrenia and previous responsiveness to oral paliperidone or risperidone, xeplion may be used without prior stabilisation with oral treatment if psychotic symptoms are mild to moderate and a long-acting injectable treatment is needed.

Den Europæiske Union - islandsk - EMA (European Medicines Agency)

aziende chimiche riunite angelini francesco s.p.a. - lurasidón - geðklofa - psycholeptics - meðferð við geðklofa hjá fullorðnum 18 ára og eldri.

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

krka, d.d., novo mesto - paliperidonum inn - forðatafla - 3 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

krka, d.d., novo mesto - paliperidonum inn - forðatafla - 6 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

krka, d.d., novo mesto - paliperidonum inn - forðatafla - 9 mg

Den Europæiske Union - islandsk - EMA (European Medicines Agency)

janssen-cilag international nv - paliperidon palmitat - geðklofa - psycholeptics - trevicta, 3 mánaða innspýting, er ætlað til viðhaldsmeðferðar við geðklofa hjá fullorðnum sjúklingum sem eru klínískt stöðugar á 1 mánaðar meðferð með paliperidon palmitati.

Den Europæiske Union - islandsk - EMA (European Medicines Agency)

janssen-cilag international n.v.   - paliperidon palmitat - geðklofa - psycholeptics - byannli (previously paliperidone janssen-cilag international) a 6 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly or 3 monthly paliperidone palmitate injectable products (see section 5.

Den Europæiske Union - islandsk - EMA (European Medicines Agency)

bioprojet pharma - pitolisant - sleep apnea, obstructive - Önnur lyf í taugakerfinu - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

krka sverige ab - mirtazapinum inn - filmuhúðuð tafla - 30 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

krka sverige ab - mirtazapinum inn - filmuhúðuð tafla - 45 mg